News from avanir pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 09, 2014, 19:20 ET
http://www.multivu.com/players/English/7266955-avanir-pharmaceuticals-pseudobulbar-affect-pba-documentary/gallery/image/a62180a1-718a-4956-ac27-9d9224620561.HR.jpg

Through Laughter and Tears Comes First-Ever Documentary about Life with PseudoBulbar Affect (PBA)

Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the initiation of production of The PBA Film Project (working title), the first-ever...

Dec 05, 2014, 16:01 ET
Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals Cancels Previously Scheduled Earnings Call

 Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that, as a result of the entry by Avanir Pharmaceuticals into an agreement and...

Dec 02, 2014, 03:35 ET
Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals To Be Acquired By Otsuka Pharmaceutical For $3.5 Billion

 Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that it has entered into a definitive agreement with Otsuka Pharmaceutical Co.,...

Nov 26, 2014, 16:54 ET
Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA

 Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete...

Nov 20, 2014, 09:00 ET
Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals to Participate in Two Conferences in December

 Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the following...

Nov 07, 2014, 08:30 ET
Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals Announces Preliminary Feedback from the FDA on AVP-825 for the Acute Treatment of Migraine

 Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that the U.S. Food and Drug Administration (FDA) has issued preliminary...

Oct 30, 2014, 16:01 ET
Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals Announces Publication of Pivotal Phase III Results from AVP-825 Acute Migraine Study in the Journal "Headache"

 Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the publication of results from TARGET, a pivotal phase III study evaluating...

Oct 13, 2014, 16:26 ET
Avanir Pharmaceuticals, Inc.  (PRNewsFoto/Avanir Pharmaceuticals, Inc.)

Avanir Pharmaceuticals Announces Presentation of AVP-923 Phase II Results in Agitation in Patients with Alzheimer's Disease at the American Neurological Association Meeting

 Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that results from the Phase II study evaluating AVP-923 for the treatment of...

Oct 08, 2014, 16:15 ET
Avanir Pharmaceuticals, Inc.  (PRNewsFoto/Avanir Pharmaceuticals, Inc.)

Avanir Pharmaceuticals to Host Investor Briefing on October 15, 2014

 Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) will host an Investor Relations Briefing on Wednesday, October 15, 2014 at 7:30 a.m. ET in New...

Oct 08, 2014, 08:30 ET
Sep 29, 2014, 09:15 ET
Avanir Pharmaceuticals, Inc.  (PRNewsFoto/Avanir Pharmaceuticals, Inc.)

Avanir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the closing of its previously announced public offering of 20,930,000 shares of its...

Sep 23, 2014, 22:00 ET
Avanir Pharmaceuticals, Inc.  (PRNewsFoto/Avanir Pharmaceuticals, Inc.)

Avanir Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the pricing of a public offering of 18,200,000 shares of its common stock in an...

Sep 22, 2014, 16:45 ET
Avanir Pharmaceuticals, Inc.  (PRNewsFoto/Avanir Pharmaceuticals, Inc.)

Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock

Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that it is offering to sell $200 million of its common stock in an underwritten public...

Sep 15, 2014, 08:30 ET
Avanir Pharmaceuticals, Inc.  (PRNewsFoto/Avanir Pharmaceuticals, Inc.)

Avanir Pharmaceuticals Announces Positive Phase II Trial Results for AVP-923 in Treatment of Agitation in Patients with Alzheimer's Disease

 Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced positive results from its phase II clinical trial evaluating the safety and...

Sep 02, 2014, 09:00 ET
Avanir Pharmaceuticals, Inc.  (PRNewsFoto/Avanir Pharmaceuticals, Inc.)

Avanir Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference

 Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the Morgan...

Aug 26, 2014, 09:00 ET
Avanir Pharmaceuticals, Inc.  (PRNewsFoto/Avanir Pharmaceuticals, Inc.)

Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder

 Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the enrollment of the first patient into a phase II study to evaluate the...

Aug 05, 2014, 16:01 ET
Avanir Pharmaceuticals, Inc.  (PRNewsFoto/Avanir Pharmaceuticals, Inc.)

Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update

Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today reported financial results for the three and nine months ended June 30, 2014. Quarterly...

Aug 05, 2014, 08:30 ET
Avanir Pharmaceuticals, Inc.  (PRNewsFoto/Avanir Pharmaceuticals, Inc.)

Avanir Pharmaceuticals to Participate in Two Conferences in August

 Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the following...

Jul 21, 2014, 09:15 ET
Avanir Pharmaceuticals, Inc.  (PRNewsFoto/Avanir Pharmaceuticals, Inc.)

Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder

 Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that the U.S. Food and Drug Administration (FDA) accepted the company's...

Jul 16, 2014, 09:00 ET
Avanir Pharmaceuticals, Inc.  (PRNewsFoto/Avanir Pharmaceuticals, Inc.)

Avanir Pharmaceuticals Announces Presentation of Positive Early Results from PRISM II Study

 Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced interim data from the phase IV PRISM II study showing that treatment with...